MDS Inc. and Danaher Corporation Receive Second Request for Information from U.S. Federal Trade Commission for MDS Analytical Technologies Sale
The Second Request relates to a global market segment that MDS and Danaher estimate generates less than
The information request was issued under notification requirements of the Hart
MDS Inc. and Danaher Corporation continue to cooperate with the FTC and currently expect the transaction, which was announced on
About Danaher Corporation
Danaher is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our portfolio of premier brands is among the most highly recognized in each of the markets we serve. Driven by a foundation provided by the Danaher Business System, our 50,000 associates serve customers in more than 125 countries and generated
About MDS Inc.
MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that customers need for the development of drugs and diagnosis and treatment of disease. MDS Inc. is a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 3,600 highly skilled people in 13 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.For further information: MDS CONTACTS: MEDIA: Janet Ko, (905) 267-4226, firstname.lastname@example.org; INVESTORS: Peter Dans, (905) 267-4230, email@example.com; DANAHER CONTACT: MEDIA AND INVESTORS: Matt McGrew, (202) 828-0850, firstname.lastname@example.org